Skip to main content
Egyptian Liver Journal

Table 4 Comparison between U/S results in the studied patients

From: Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)

N = 200

At the start of treatment

After 1 month of treatment

At the end of treatment

p-value

Abdominal ultrasounds

 Normal

115 (57.5%)

115 (57.5%)

114 (57%)

p1 = 1.0 NS

 Fatty

57 (28.5%)

57 (28.5%)

58 (29%)

p2 = 0.993NS

 Cirrhotic

28 (14%)

28 (14%)

28 (14%)

p3 = 0.993 NS

  1. X2: chi-square test
  2. S: p-value < 0.05 is considered significant
  3. HS: p-value < 0.001 is considered highly significant
  4. P1: refers to the statistical difference between the start of DAA and 1 month after DAA
  5. P2: refers to the statistical difference between the start of DAA and the end of DAA
  6. P3: refers to the statistical difference between 1 month after DAA and the end of DAA
Back to article page